Myopia Management in Kolkata
Updating the Prescription Is Not Managing the Myopia
Kolkata children who return to the optician every 12–18 months for a stronger prescription are not receiving myopia management - they are receiving compensation for a prescription that keeps climbing. Myopia is a structural change to the eye. A stronger lens corrects vision today and does nothing to slow the progression that creates the next prescription change. Caring Vision Therapy offers evidence-based myopia control - orthokeratology, MiSight contact lenses, LAMP low-dose atropine, and optical interventions - assessed and managed via telehealth for Kolkata families. In-clinic services are available at our Chennai and Hyderabad clinics.
Why Kolkata's Study Environment Accelerates Myopia Progression
Myopia progresses faster in children who spend more time on sustained near-work and less time outdoors in natural light. Kolkata's academic calendar - school from 7 AM, tuition sessions through the afternoon, homework until late evening, and board exam coaching on weekends - gives children one of the highest sustained near-work loads in the country. Combined with Kolkata's relatively limited outdoor time for children in competitive schools, this creates exactly the environmental conditions that drive rapid myopia progression.
A La Martiniere or Don Bosco student who begins myopia at age 8 with –1.00 D and continues annual prescription updates without any myopia control intervention has a high probability of reaching –5.00 D or higher by their mid-teens. High myopia (above –5.00 D) significantly increases lifetime risk of retinal detachment, glaucoma, macular degeneration, and cataract - irrespective of correction. The goal of myopia management is not better vision today. It is a lower final prescription and reduced risk of these complications decades from now.
What Optical Compensation Cannot Do
| Annual Prescription Update | Myopia Management Programme |
|---|---|
| Corrects current blurring with stronger lens | Actively slows the rate of axial eye elongation |
| No effect on progression rate | 30–60% reduction in progression (evidence-based) |
| Prescription continues to climb yearly | Lower final prescription at adulthood |
| High myopia risk unaddressed | Reduces lifetime risk of myopia-related complications |
| Single modality: spectacle or contact lens | Multi-modal: atropine, ortho-k, MiSight, lifestyle guidance |
Evidence-Based Myopia Control for Kolkata Children
There is no single best myopia control strategy. The right approach depends on the child's age, current prescription, progression rate, lifestyle, and compliance factors. Our programme selects from the following evidence-based options:
- Low-dose atropine (LAMP protocol) - 0.01% to 0.05% atropine eye drops; the LAMP2 trial showed 0.05% provides superior control with minimal side effects. Suitable for most school-age children; easy to administer at home
- Orthokeratology (Ortho-K) - overnight contact lenses that reshape the cornea temporarily, providing clear daytime vision without glasses while slowing axial elongation. Strong evidence base, good control rates in East Asian-descent populations
- MiSight 1 day contact lenses - dual-focus daily disposable lenses that correct distance vision while creating peripheral defocus signals that slow eye growth. CooperVision MiSight is the only contact lens with an EU and US FDA myopia control indication
- Myopilux / Stellest spectacle lenses - high-addition spectacle lenses with peripheral defocus design; suitable for children not ready for contact lenses
- Outdoor time counselling - evidence shows 80–120 minutes per day of outdoor time in natural light slows myopia onset and progression independent of any other intervention
Three Prescription Changes in Four Years
A 10-year-old student at a CBSE school near Behala starts with –1.25 D in Class 5. By Class 8, after three annual prescription updates, she is at –3.50 D. Both parents have prescriptions above –4.00 D; her family optician in Gariahat has updated her glasses each time without ever discussing myopia control. Her grandmother, who has myopic macular degeneration, is losing reading vision in her sixties.
At –3.50 D and progressing at approximately –0.75 D per year, her projected adult prescription without intervention is –7.00 D or higher. A myopia management programme combining 0.05% atropine drops and Ortho-K is initiated. Progression over the following year is –0.25 D. The annual rate of change is not eliminated, but it is dramatically reduced - each year the gap between her managed trajectory and her projected unmanaged trajectory widens.
Questions Kolkata Parents Ask About Myopia Management
An ophthalmologist told us myopia is genetic and there is nothing to do except update the prescription. Is that still the current advice?
This reflects older clinical consensus. Myopia does have a strong genetic component - children with two myopic parents have a significantly higher risk. However, large multicentre trials (ATOM2, LAMP, COMET, MiSight 3-year studies) have established that progression rate is modifiable. Atropine at 0.05% reduces annual progression by approximately 50–75% in most studies; orthokeratology reduces axial elongation by 30–60% depending on design. The genetic predisposition sets the risk level; the management intervention modifies how fast that risk converts into higher prescription. Hospital eye departments typically do not offer myopia control programmes - this is a subspecialty area in behavioural optometry and contact lens practice.
At what prescription level should myopia management start? My child is currently –1.50 D.
The current evidence-based guidance is that myopia management should start as early as myopia is confirmed and demonstrably progressing - not at a particular prescription threshold. At –1.50 D in a 9- or 10-year-old who has been progressing, the child has several years of potential progression ahead. Starting management early, when the prescription is still lower, results in a lower adult final prescription than starting when the prescription has already reached –3.00 D or higher. Waiting for a specific threshold means accepting progression that could have been slowed. The key decision criteria are: age of onset, rate of progression, and family history - not the current prescription level alone.
Are atropine drops safe for a 9-year-old? I am worried about side effects.
Low-dose atropine (0.01%–0.05%) has been extensively studied in paediatric populations. The LAMP and ATOM2 trials, which included children from ages 6–12, showed no clinically significant systemic side effects. At these concentrations, pupil dilation and near-focusing blur - the side effects associated with therapeutic-dose atropine - are minimal or absent. The 0.05% dose used in the LAMP2 protocol is now the most widely recommended starting dose, offering superior myopia control with a side effect profile similar to 0.01%. Your child will have the dosing protocol explained fully before initiation, and the programme is reviewed at regular intervals.
Can we manage the myopia programme entirely via telehealth from Kolkata?
Yes, with one practical consideration: the atropine prescription and any contact lens fitting components require a local optometrist or ophthalmologist in Kolkata to carry out the physical measurement (axial length, cycloplegic refraction) at the start and at annual review points. We coordinate with local practitioners in Kolkata for these measurement components, then manage the myopia control protocol, monitoring, dose adjustments, and progress reviews remotely via telehealth. For most families in Kolkata, this hybrid model - local measurement, remote management - is the most practical approach.
My son has –5.00 D already at age 14. Is it too late to start myopia management?
It is not too late. At –5.00 D and age 14, your son's eye is likely still growing - most myopia stabilises between ages 18 and 22. Two to four more years of unmanaged progression at –0.50 to –0.75 D per year could add –1.00 D to –3.00 D to his final prescription, pushing him further into high myopia territory. Even at a late stage, slowing progression by 50% means his final adult prescription could be meaningfully lower than his unmanaged trajectory. The risk reduction for retinal complications is proportional to final prescription - every dioptre avoided matters.
Related Kolkata Vision Services
Myopia Management · Pan-India
Myopia Management Available in Your City
In-clinic in Chennai & Hyderabad - telehealth for Kolkata and more cities.